Janssen Pharmaceuticals, Inc.

1125 Trenton-Harbourton Road P.O. Box 200,
Titusville, New Jersey 08560
United States,
(609)730-2000
www.janssenpharmaceuticalsinc.com

Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (0.4/yr) # 1 1 - 1 - - 3
vol $245M $152M $397M
Sell (0.0/yr) # 2 - - - - - 2
vol $345M $345M
  5

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Peninsula Pharmaceuticals, Inc.
$245M (2005-06-30)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Ortho Dermatologics, Inc.
$345M (2011-07-15)

According to our data here at Mergr, Janssen Pharmaceuticals has acquired 4 companies, including 2 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 2 assets.

Janssen Pharmaceuticals’ largest acquisition to date was in 2005, when it acquired Peninsula Pharmaceuticals for $245M. It’s largest disclosed sale occurred in 2011, when it sold Ortho Dermatologics to Valeant Pharmaceuticals International for $345M. Janssen Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 419 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Janssen Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.